Globe Life shares have climbed 26.2% over the past six months to $178.90, outperforming the S&P 500 by 19.4 percentage points. Despite the rally, analysts at StockStory are not recommending the stock, citing tepid 4.8% annualized revenue growth over five years and soft net premiums earned growth of 4.9% annually over the past two years. Book value per share has accelerated to 20.8% annual growth over two years, reaching $78.12, but the stock trades at 2.1 times forward price-to-book. The analysts suggest there are better investment opportunities elsewhere.
Globe Life IncStock price up 26.2% but analysts cautious due to tepid revenue growth and high valuation.